Program in chemoenzymatic synthesis: Morphine and Amaryllidaceae alkaloids, chiral building blocks, and design of new asymmetric protocols and reagents

化学酶合成项目：吗啡和石蒜科生物碱、手性结构单元以及新的不对称方案和试剂的设计

• 批准号: 262022-2013
• 负责人: Hudlicky, Tomas
• 金额: $ 5.03万
• 依托单位: Brock University
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=632773
• 关键词: Program; chemoenzymatic; synthesis; Morphine; Amaryllidaceae

The central theme of our program involves a combination of chemical and biological methods to maximize efficiency in the manufacturing of important organic compounds. These range from natural products, their medicinally important unnatural derivatives, chiral building blocks and reagents, and chiral polymers. Emphasis is placed on brevity of design and environmentally benign ("green") execution. These goals are accomplished by multi-generational pursuit of the targets and continuous improvement in synthetic protocols. In addition, and through collaborations with industry, process improvement research is being conducted for compounds of commercial significance, for example, opiate-derived analgesics. During the next funding period, our well-integrated program expands in a number of new directions and is focused on the following areas: (1) Biotransformations of aromatics and provision of chiral building blocks for target-oriented synthesis. (2) Total synthesis of unnatural derivatives of Amaryllidaceae alkaloids with anti-cancer activities. (3) New generation designs for morphine (pain control) and Aspidosperma alkaloids (anti-cancer). (4) Catalytic and enzymatic methods for improved N-demethylation of opiates (pain control). (5) New [5+2] and [5+2+1] annulation protocols. (6) Synthesis of new derivatives of Tamiflu with anti-viral and anti-cancer activities. (7) Design of an enzyme mimic reagent for dihydroxylation of aromatics. Overall, the proposed research addresses focused investigations in asymmetric synthesis driven by the use of biological methods for a greater "green" component. The need for more efficient manufacturing processes is essential in order to save diminishing resources and protect the environment. Our research addresses future solutions to manufacturing of important compounds and materials. Highly qualified personnel at undergraduate, graduate, and postdoctoral levels will be trained in biocatalysis, synthesis, catalyst design, and process-development for the Canadian pharmaceutical sector and/or academic appointments. We expect to prepare marketable medicinal agents for commercialization.

我们计划的中心主题涉及化学和生物方法的结合，以最大限度地提高生产重要有机化合物的效率。这些范围包括天然产物，其具有重要药用意义的非天然衍生物，手性构建块和试剂以及手性聚合物。重点放在简洁的设计和环保（“绿色”）执行。这些目标是通过对目标的多代追求和对合成方案的不断改进来实现的。此外，通过与工业界合作，正在对具有商业意义的化合物进行工艺改进研究，例如阿片衍生镇痛药。在下一个资助期内，我们整合良好的项目将扩展到一些新的方向，并专注于以下领域：(1)芳烃的生物转化和为靶向合成提供手性构建块。(2)全合成具有抗癌活性的amarylliedaceae生物碱非天然衍生物。(3)新一代吗啡（止痛）和蛇皮草生物碱（抗癌）的设计。(4)改善阿片类药物n -去甲基化（疼痛控制）的催化和酶促方法。(5)新的[5+2]和[5+2+1]环形方案。(6)合成具有抗病毒和抗癌活性的达菲新衍生物。(7)芳烃二羟基化酶模拟试剂的设计。总的来说，拟议的研究解决了由使用生物方法驱动的不对称合成的重点调查，以获得更大的“绿色”成分。为了节约日益减少的资源和保护环境，需要更有效的制造过程是必不可少的。我们的研究解决了重要化合物和材料制造的未来解决方案。本科、研究生和博士后水平的高素质人才将接受生物催化、合成、催化剂设计和工艺开发方面的培训，为加拿大制药部门和/或学术任命服务。我们期望为商业化准备适销对路的药品。